REFERENCES
1. Yeh MW, Ituarte PHG, Zhou HC, Nishimoto S, Liu I-LA, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013 Mar;98(3):1122–9.
2. Ruda JM, Hollenbeak CS, Stack BC. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2005 Mar;132(3):359–72.
3. Day KM, Elsayed M, Monchik JM. No Need to Abandon Focused Unilateral Exploration for Primary Hyperparathyroidism with Intraoperative Monitoring of Intact Parathyroid Hormone. J Am Coll Surg. 2015 Aug;221(2):518–23.
4. Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011 Mar;253(3):585–91.
5. Carneiro-Pla DM, Solorzano CC, Irvin GL. Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg. 2006 May;202(5):715–22.
6. Bachar G, Mizrachi A, Hadar T, Feinmesser R, Shpitzer T. Role of parathyroid hormone monitoring during parathyroidectomy. Head Neck. 2011 Dec;33(12):1754–7.
7. Gawande AA, Monchik JM, Abbruzzese TA, Iannuccilli JD, Ibrahim SI, Moore FD. Reassessment of parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism after 2 preoperative localization studies. Arch Surg Chic Ill 1960. 2006 Apr;141(4):381–4; discussion 384.
8. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg Chic Ill 1960. 2005 May;140(5):472–8; discussion 478-479.
9. Levy JM, Kandil E, Yau LC, Cuda JD, Sheth SN, Tufano RP. Can ultrasound be used as the primary screening modality for the localization of parathyroid disease prior to surgery for primary hyperparathyroidism? A review of 440 cases. ORL J Oto-Rhino-Laryngol Its Relat Spec. 2011;73(2):116–20.
10. Bhansali A, Masoodi SR, Bhadada S, Mittal BR, Behra A, Singh P. Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison with radionuclide scintigraphy and surgery. Clin Endocrinol (Oxf). 2006 Sep;65(3):340–5.
11. Stern S, Tzelnick S, Mizrachi A, Cohen M, Shpitzer T, Bachar G. Accuracy of Neck Ultrasonography in Predicting the Size and Location of Parathyroid Adenomas. Otolaryngol–Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg. 2018 Dec;159(6):968–72.
12. Coan KE, Yen TWF, Carr AA, Evans DB, Wang TS. Confirmation of Parathyroid Tissue: Are Surgeons Aware of New and Novel Techniques? J Surg Res. 2020 Feb;246:139–44.
13. Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014 Oct;99(10):3561–9.
14. Riss P, Scheuba C, Asari R, Bieglmayer C, Niederle B. Is minimally invasive parathyroidectomy without QPTH monitoring justified? Langenbecks Arch Surg. 2009 Sep;394(5):875–80.
15. Bergenfelz AOJ, Hellman P, Harrison B, Sitges-Serra A, Dralle H, European Society of Endocrine Surgeons. Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg. 2009 Sep;394(5):761–4.
16. Helbrow J, Owais AE, Sidwell AG, Frank LM, Lucarotti ME. The use of intraoperative parathyroid hormone monitoring in minimally invasive parathyroid surgery. Ann R Coll Surg Engl. 2016 Sep;98(7):516–9.
17. Sartori PV, Saibene AM, Leopaldi E, Boniardi M, Beretta E, Colombo S, et al. Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up? Eur Arch Oto-Rhino-Laryngol Off J Eur Fed Oto-Rhino-Laryngol Soc EUFOS Affil Ger Soc Oto-Rhino-Laryngol - Head Neck Surg. 2019 Jan;276(1):267–72.
18. Suliburk JW, Sywak MS, Sidhu SB, Delbridge LW. 1000 minimally invasive parathyroidectomies without intra-operative parathyroid hormone measurement: lessons learned. ANZ J Surg. 2011 May;81(5):362–5.
19. Najafian A, Kahan S, Olson MT, Tufano RP, Zeiger MA. Intraoperative PTH May Not Be Necessary in the Management of Primary Hyperparathyroidism Even with Only One Positive or Only Indeterminate Preoperative Localization Studies. World J Surg. 2017 Jun;41(6):1500–5.
20. Nair CG, Babu MJC, Jacob P, Menon R, Mathew J. Is intraoperative parathyroid hormone monitoring necessary in symptomatic primary hyperparathyroidism with concordant imaging? Indian J Endocrinol Metab. 2016 Aug;20(4):512–6.
21. Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg. 2012 Mar;214(3):260–9.
22. Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003 Dec;134(6):973–9; discussion 979-981.
23. Morris LF, Zanocco K, Ituarte PHG, Ro K, Duh Q-Y, Sturgeon C, et al. The value of intraoperative parathyroid hormone monitoring in localized primary hyperparathyroidism: a cost analysis. Ann Surg Oncol. 2010 Mar;17(3):679–85.
24. Wang TS, Cheung K, Farrokhyar F, Roman SA, Sosa JA. Would scan, but which scan? A cost-utility analysis to optimize preoperative imaging for primary hyperparathyroidism. Surgery. 2011 Dec;150(6):1286–94.
25. Badii B, Staderini F, Foppa C, Tofani L, Skalamera I, Fiorenza G, et al. Cost-benefit analysis of the intraoperative parathyroid hormone assay in primary hyperparathyroidism. Head Neck. 2017 Feb;39(2):241–6.